Spitz tumors in children - A grading system for risk stratification

被引:149
作者
Spatz, A
Calonje, E
Handfield-Jones, S
Barnhill, RL
机构
[1] Johns Hopkins Med Inst, Div Dermatopathol & Oral Pathol, Baltimore, MD 21287 USA
[2] Inst Gustave Roussy, Dept Pathol, Villejuif, France
[3] St Thomas Hosp, St Johns Inst Dermatol, London, England
关键词
D O I
10.1001/archderm.135.3.282
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To describe a grading system for risk stratification of atypical Spitz tumors in children and adolescents. In some circumstances, unequivocal distinction between Spitz nevus and melanoma is practically impossible. It is likely that these lesions for which we lack specific diagnostic criteria represent a broad histological continuum extending from benign to malignant tumors. Therefore, we propose that Spitz tumors be categorized into low-, intermediate-, or high-risk categories based on the accumulation of abnormal features. Design: Retrospective study. Settings: Institutional practice. Patients: We present 30 cases of atypical Spitz tumors in patients younger than 18 years evaluated for at least 3 years or in whom a metastatic event developed during this period. Intervention: None. Main Outcome Measure: The grading system was formulated after data collection. Results: Among the parameters studied, only diagnosis at age greater than 10 years, diameter of the lesion greater than 10 mm, presence of ulceration, involvement of the subcutaneous fat (level V), and mitotic activity of at least 6/mm(2) carried a likelihood ratio greater than 1.50 and were therefore used for the grading system. Conclusion: The application of an objective grading system, such as the one described herein for the first time, is the first step in providing useful information for the management of atypical Spitz tumors.
引用
收藏
页码:282 / 285
页数:4
相关论文
共 26 条
[1]   Discordance among expert pathologists in diagnosis of melanocytic neoplasms [J].
Ackerman, AB .
HUMAN PATHOLOGY, 1996, 27 (11) :1115-1116
[2]  
ALLEN AC, 1953, CANCER-AM CANCER SOC, V6, P1, DOI 10.1002/1097-0142(195301)6:1<1::AID-CNCR2820060102>3.0.CO
[3]  
2-C
[4]  
BARNHILL RL, 1995, CANCER, V76, P1833, DOI 10.1002/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO
[5]  
2-L
[6]  
Barnhill RL, 1998, TXB DERMATOPATHOLOGY, P537
[8]  
BUSAM KJ, 1995, PATHOLOGY MELANOCYTI, P97
[9]   SPITZ-NEVI [J].
CASSO, EM ;
GRINJORGENSEN, CM ;
GRANTKELS, JM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (06) :901-913
[10]  
CLARK WH, 1969, CANCER RES, V29, P705